Alumis (ALMS) Receivables - Other (2023 - 2025)

Alumis' (ALMS) quarterly Receivables - Other came in at $1.3 million in Q4 2025, up 92.41% year-on-year from $698000.0 in Q4 2024, and down 32.41% on a QoQ basis from $2.0 million in Q3 2025.

Alumis (ALMS) Receivables - Other (2023 - 2025) Analysis & Trends

Alumis (ALMS) has 3 years of Receivables - Other data on file, last reported at $1.3 million in Q4 2025.

  • On a quarterly basis, Receivables - Other rose 92.41% year-over-year to $1.3 million in Q4 2025; TTM through Dec 2025 was $1.3 million, a 92.41% increase from a year earlier, with the FY2025 full-year figure at $1.3 million, up 92.41% from the prior year.
  • Receivables - Other for Q4 2025 stood at $1.3 million, down from $2.0 million in the prior quarter.
  • Over the last five years, Receivables - Other for ALMS reached as high as $2.3 million in Q2 2025 and fell as low as $108000.0 in Q4 2023.
  • Historically, Receivables - Other has averaged $984375.0 across 3 years, with a median of $732500.0 in 2024.
  • On a YoY basis, Receivables - Other climbed as much as 701.06% in 2025 and fell as far as 92.41% in 2025.
  • Year by year, Receivables - Other stood at $108000.0 in 2023, then surged by 546.3% to $698000.0 in 2024, then surged by 92.41% to $1.3 million in 2025.
  • Per Business Quant data, the three most recent Receivables - Other figures were $1.3 million in Q4 2025, $2.0 million in Q3 2025, and $2.3 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Alumis 2.41 Bn 2.10 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 1.34 Mn
Dec 31, 2025 1.34 Mn
Sep 30, 2025 1.99 Mn
Sep 30, 2025 1.99 Mn
Jun 30, 2025 2.27 Mn
Jun 30, 2025 2.27 Mn
Mar 31, 2025 422,000.00
Mar 31, 2025 422,000.00
Dec 31, 2024 698,000.00
Dec 31, 2024 698,000.00
Sep 30, 2024 767,000.00
Sep 30, 2024 767,000.00
Jun 30, 2024 283,000.00
Jun 30, 2024 283,000.00
Dec 31, 2023 108,000.00
Dec 31, 2023 108,000.00